These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3919093)

  • 1. Production and response to interleukin 2 in vitro and in vivo after bone marrow transplantation in mice.
    Merluzzi VJ; Welte K; Last-Barney K; Mertelsmann R; Souza L; Boone T; Savage DM; Quinn D; O'Reilly RJ
    J Immunol; 1985 Apr; 134(4):2426-30. PubMed ID: 3919093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS; Malek TR; Hargrove ME; Ting CC
    J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemic effect of interleukin-2 on spontaneous development of leukemia after H-2-compatible allogenic bone marrow transplantation in AKR/J mice.
    Hashino S
    Hokkaido Igaku Zasshi; 1994 May; 69(3):601-13. PubMed ID: 7927184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo administration of cytokine in allogeneic bone marrow chimeras.
    Imamura M; Fujimoto H; Hashino S; Fukuhara T; Kobayashi M; Kasai M; Sakurada K; Miyazaki T
    Immunobiology; 1990 Jun; 180(4-5):441-57. PubMed ID: 1697845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras.
    Shih CC; Truitt RL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2664-7. PubMed ID: 2950639
    [No Abstract]   [Full Text] [Related]  

  • 10. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self.
    Vargo PM; Battisto JR
    J Immunol; 1984 Jun; 132(6):2796-801. PubMed ID: 6233362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors.
    Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ
    J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
    Gautam SC; Hilfiker ML; Battisto JR
    J Immunol; 1983 Feb; 130(2):533-7. PubMed ID: 6217243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
    Maki T; Gottschalk R; Wood ML; Monaco AP
    J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
    J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
    Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
    J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymectomized, irradiated, and bone marrow-reconstituted chimeras have normal cytolytic T lymphocyte precursors but a defect in lymphokine production.
    Duprez V; Maziarz R; Weinberger O; Burakoff SJ
    J Immunol; 1984 May; 132(5):2185-9. PubMed ID: 6232313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice.
    Umiel T; Pecht M; Trainin N
    J Biol Response Mod; 1984 Aug; 3(4):423-34. PubMed ID: 6332883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of mononuclear cells infiltrating into tumors. II. Differential ability of mononuclear cells obtained from various tissues to produce helper factors that are involved in the generation of cytotoxic cells.
    Uede T; Kohda H; Ibayashi Y; Osawa H; Diamantstein T; Kikuchi K
    J Immunol; 1985 Nov; 135(5):3243-51. PubMed ID: 3900205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.